Chemotherapy Biotherapy Certification ONS Practice Testq

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ONS Chemotherapy Biotherapy Certification Exam. Leverage flashcards and multiple choice questions, complete with hints and explanations. Equip yourself for exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


What type of cancers is least targeted by concurrent chemo and radiation therapy?

  1. Breast cancer

  2. Prostate cancer

  3. Head and neck cancer

  4. Gastric cancer

The correct answer is: Breast cancer

Concurrent chemotherapy and radiation therapy is often most effective for specific types of cancers that are responsive to such combined treatment strategies. In the case of breast cancer, while concurrent treatment is utilized in some instances, it is less commonly the standard approach compared to other cancer types listed. Head and neck cancer and gastric cancer frequently benefit from concurrent therapy due to the aggressive nature of these cancers and their locations, which often necessitate a combined treatment approach to improve outcomes. Prostate cancer, while typically managed with radiation, tends to be treated more often with hormone therapy rather than concurrent chemotherapy. Breast cancer often involves surgery as a primary treatment method, in combination with adjuvant therapies such as hormonal treatment, making it less reliant on concurrent chemotherapy and radiation compared to the other cancer types mentioned. Thus, the answer highlights that breast cancer is least targeted by the combined modality of concurrent chemotherapy and radiation therapy, reflecting treatment patterns typically seen in clinical practice.